-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Xponential Fitness, Lowers Price Target to $10

Benzinga·03/02/2026 16:06:59
Listen to the news
Guggenheim analyst John Heinbockel maintains Xponential Fitness (NYSE:XPOF) with a Buy and lowers the price target from $12 to $10.